Ardelyx reported $-12503000 in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Abbott USD 2.07B 105M Jun/2025
Amgen USD 2.26B 1.34B Jun/2025
Ardelyx USD -12503000 20.63M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Life Technologies USD -367334 15.45M Jun/2025
Sanofi EUR 1.51B 704.8M Jun/2025
TG Therapeutics USD 34.84M 22.62M Jun/2025
United Therapeutics USD 276.9M 105.9M Jun/2025